[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Monash University Malaysia\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":154},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,42,77,103,124],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100647825","cpharm---crc-study-100647825",false,"NCT07714291","CPHARM - CRC Study","Community Pharmacy-Based Health-Seeking Behaviour and Colorectal Cancer Screening Uptake Among Malaysian Adults","Inclusion Criteria:\n\n* Adults aged 50 to 75 years\n* Visiting participating community pharmacies during the study period\n* Able to provide informed consent\n* Willing to complete the study questionnaire\n* Willing to provide consent for follow-up assessment of: iFOBT provision, iFOBT testing completion, iFOBT results\n\nExclusion Criteria:\n\n* Previous diagnosis of colorectal cancer\n* History of colonoscopy within the recommended screening interval (within past 1 year)\n* Currently experiencing symptoms suggestive of colorectal cancer\n* Having a first-degree relative diagnosed with colorectal cancer",true,"ALL","50 Years","75 Years",{"count":21,"type":22},316,"ESTIMATED","INTERVENTIONAL",[25],"NA","Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low.\n\nCommunity pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.",[28],"Colorectal Cancer","NOT_YET_RECRUITING","2026-07-19",{"date":32,"type":33},"2026-07-21","ACTUAL",{"date":35,"type":22},"2026-11",{"date":37,"type":22},"2027-01",{"name":39,"class":40},"Monash University Malaysia","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":50,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":54,"conditions":55,"keywords":59,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":41},"100646107","evaluating-the-efficacy-of-a-tocotrienols-loaded-dressing-in-wound-care-for-pressure-ulcers-100646107","NCT07694583","Evaluating the Efficacy of a Tocotrienols-Loaded Dressing in Wound Care for Pressure Ulcers","A Prospective, Double-Blinded, Randomized Controlled Trial to Evaluate the Efficacy of a Formulated Dressing Containing Tocotrienols in Wound Care for Pressure Ulcers","TOCOWO","Inclusion Criteria:\n\n* The included participants or caretakers are older than 18 years with at least one pressure ulcer that was stage I-II as classified by the National Pressure Ulcer Advisory Panel and the European Pressure Ulcer Advisory Panel (NPUAP\u002FEPUAP)\n* Exhibited a pressure ulcer surface area of \\\u003C80 cm2 (multiplication of the major and minor diameters of the wound surface)\n* PUSH (version 3.0) score of \\>5 that was likely to heal during the 6-month study period\n* Provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n\nExclusion Criteria:\n\n* Stage III \\& IV pressure ulcers requiring different standard of care\n* Multiple known allergies to other types of dressings\n* Wound deemed to have an infection\n* Area of skin necrosis that requires special dressing and\u002For topical antibiotic treatment\n* Any (medical) conditions that would, in the opinion of the investigator, potentially compromise the safety or compliance of the subject or may preclude the subjects' successful completion of the clinical trial\n* Allergic to dressings during 24-hour pre-study allergy test","18 Years",{"count":52,"type":22},114,[25],"The goal of this clinical trial is to investigate the effects of the dressing containing Tocotrienols on patients with stage 1 and stage 2 pressure ulcers. The main questions it aims to answer are:\n\n* Will the dressing containing Tocotrienols lead to a reduction in the Pressure Ulcer Scale for Healing (PUSH) Score?\n* Will the dressing containing Tocotrienols help heal the participants' pressure ulcer wounds?\n* Will the dressing containing Tocotrienols lead to reduction in wound surface area?\n* What is the percentage of patients with completely healed wounds by the end of the study?\n\nResearchers will compare Tocotrienols-loaded formulated dressing to conventional dressing (standard of care as control) in pressure ulcers.\n\nParticipants will:\n\n* Have their pressure ulcers checked by a study doctor to ensure they are infection-free and suitable ulcer fitting the inclusion criteria\n* Undergo 24-hour allergy testing with patch of Tocotrienol-loaded dressing and standard hydrocolloid dressing\n* Be randomly assigned to one of three groups if they qualify: control, vehicle-control, or treatment group\n* Assess skin sensitivity testing the next day, and if qualify, will be started on first dosing.\n* Attend follow-up visits on days 1, 3, 5, 7, 15, 22, 29, 35 and 43, where additional questions and assessments will be completed.",[56,57,58],"Pressure Ulcer Stage 1","Pressure Ulcers Stage II","Pressure Injuries",[60,61,62,63,64,65,66,67],"Dressing membrane","Tocotrienols","Wound care","Pressure Ulcer","hydrocolloid","pressure injury","PUSH score","wound size reduction","RECRUITING","2026-07-13",{"date":71,"type":33},"2026-07-15",{"date":73,"type":33},"2026-01-21",{"date":75,"type":22},"2027-12",{"name":39,"class":40},{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":4,"eligibilityCriteria":83,"healthyVolunteers":16,"sex":17,"minAge":50,"maxAge":4,"enrollmentInfo":84,"targetDuration":4,"studyType":23,"phases":86,"briefSummary":87,"conditions":88,"keywords":92,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":41},"100644903","educational-intervention-on-oral-anticancer-agents-for-community-pharmacists-100644903","NCT07677176","Educational Intervention on Oral Anticancer Agents for Community Pharmacists","Feasibility and Acceptability of an Educational Intervention on Oral Anticancer Agents for Community Pharmacists: a Pilot Randomized Controlled Trial","Inclusion Criteria:\n\n* Currently a registered pharmacist working in community pharmacy in Malaysia\n* Provided written informed consent\n* Ability to read and understand English\n* Basic digital literacy and ability to use computer\u002Ftablet devices\n* Willingness to participate in all study procedures including surveys and potential interviews\n\nExclusion Criteria:\n\n• Previous participation in educational intervention stakeholder evaluation",{"count":85,"type":22},40,[25],"The overall aim of this study is to develop and test the feasibility and acceptability of an educational intervention for community pharmacists to provide support to patients receiving oral anticancer agents (OAAs) in the community. This pilot randomized controlled trial aims to evaluate the feasibility, acceptability, and preliminary effect of an educational intervention on the knowledge and confidence in managing OAAs among community pharmacists in Malaysia.\n\nPRIMARY OBJECTIVE • To evaluate the feasibility and acceptability of the educational intervention on OAAs among community pharmacists.\n\nSECONDARY OBJECTIVE\n\n• To obtain preliminary data on the effect of the educational intervention to improve community pharmacists' knowledge and confidence in managing OAAs.\n\nParticipants will be randomly assigned to either the intervention group or control group in a 1:1 ratio using block randomization. After enrolling, participants will be asked to complete a baseline survey assessing their knowledge and confidence in managing OAAs. Immediately after completing the intervention and 4 weeks after the intervention, participants in the intervention group and control group will repeat the same questionnaire to assess changes in their knowledge and confidence.\n\nResults of this pilot study will inform the design of a larger study to test whether this intervention improves community pharmacists' knowledge and confidence. This research may help better prepare community pharmacists to provide high-quality care to patients receiving OAAs.",[89,90,91],"Oral Anti-Tumor Drugs","Oral Antineoplastic Agents","Oral Anticancer Drugs",[93,94,95],"Community pharmacists","Oral anticancer agents","Educational intervention",{"date":97,"type":33},"2026-07-14",{"date":99,"type":22},"2026-08",{"date":101,"type":22},"2026-12",{"name":39,"class":40},{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":4,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":17,"minAge":50,"maxAge":4,"enrollmentInfo":110,"targetDuration":4,"studyType":23,"phases":112,"briefSummary":113,"conditions":114,"keywords":4,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":41},"100592621","el-shin-therapy-for-depressive-symptoms-100592621","NCT06995807","EL-SHIN Therapy for Depressive Symptoms","Enhancing the Efficacy of Depression and Low Mood Treatment: A Novel Adjunctive Approach","Inclusion Criteria:\n\n* Age: Above 18 yrs old\n* DASS-21 scores:\n\n\"Moderately Depressed (Score: 14-20)\", \"Moderately Anxious (Score: 10-14)\" \\& \"Moderately Stressed (Score: 19-25)\"\n\n* Non-Muslim (Due to legal restriction in Malaysia for this religion)\n* English literate\n* Believers in Creationism\n\nExclusion Criteria:\n\n* Muslim (legal restrictions in Malaysia for this religion).\n* Non-English literate (research will be conducted in English only).\n* Individuals with any other medical conditions or on current medication To reduce potential complications or confounding factors).",{"count":111,"type":22},80,[25],"This is a research aiming to find the effectiveness of an innovative therapy, EL-SHIN THERAPY, in ameliorating depressive symptoms.",[115],"Depressive Disorder","2025-11-27",{"date":118,"type":33},"2025-12-01",{"date":120,"type":33},"2025-06-01",{"date":122,"type":22},"2027-05",{"name":39,"class":40},{"id":125,"slug":126,"hasResults":11,"nctId":127,"briefTitle":128,"officialTitle":129,"acronym":130,"eligibilityCriteria":131,"healthyVolunteers":16,"sex":17,"minAge":50,"maxAge":4,"enrollmentInfo":132,"targetDuration":4,"studyType":23,"phases":134,"briefSummary":135,"conditions":136,"keywords":141,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":41},"100573286","heat-adaptation-through-community-based-approaches-and-research-at-seaco-structural-and-behavioural-interventions-heat-care-100573286","NCT06744309","Heat Adaptation Through Community-based Approaches and Research at SEACO: Structural and Behavioural Interventions (Heat Care)","Heat Adaptation Through Community-based Approaches and Research at SEACO: Structural and Behavioural Interventions","Heat Care","Individual Inclusion Criteria:\n\n* Adults aged at least 18 years old\n* Willing to participate in all study components\n* Consent to roof painting and installation of heat and humidity measurement devices\n* Consent to wear the supplied wearables (Garmin Vivosmart 5) for data collection\n* No plans to relocate during the study period\n* Possess a smartphone for receiving health education materials\n\nIndividual Exclusion Criteria:\n\n* Individuals belonging to one household with existing participants\n* Bedridden individuals or those requiring assistance in movement\n\nHousehold Inclusion Criteria:\n\n* Single-story house\n* Main house measurement less than 1200 sqft\n* Built with brick or brick and wooden\n* Roof made of zinc, ceramic\u002Fclay, or mixed, suitable for cool roof painting\n* Minimal to no requirement for roof repair\n* No plans for renovation during the study period\n\nHousehold Exclusion Criteria:\n\n* Double-story houses, shops, or empty houses\n* Houses with the facility to sprinkle water on the roof",{"count":133,"type":22},1000,[25],"The goal of this clinical trial is to learn if structural and behavioral interventions can mitigate the health effects of extreme heat in rural Malaysian communities. The study focuses on implementing cool roofs (a passive cooling system) and heat literacy education to improve heat adaptation behaviors. The main questions it aims to answer are:\n\n* Does the implementation of cool roofs reduce indoor temperatures and related heat stress in rural households?\n* Does heat literacy education improve community awareness and behaviors related to coping with extreme heat?\n\nResearchers will compare four groups: one receiving both cool roofs and heat literacy interventions, one receiving only the cool roof intervention, one receiving only heat literacy education, and a control group receiving neither intervention. Participants will be asked to:\n\n* Have their roofs painted with UV-resistant white paint (for cool roof intervention groups).\n* Participate in educational sessions and training on heat-related health risks and coping strategies (for heat literacy intervention groups).\n* Complete baseline and follow-up surveys at 3, 6, and 12 months.\n* Wear a Garmin Vivosmart 5 sensor for two weeks during each data collection period to monitor heart rate, physical activity, and sleep patterns.",[137,138,139,140],"Climate Change","Heat; Weather","Heat Effect","Heat; Excess",[142,143,144,145],"heat health","heat literacy","thermotolerance","Rising average temperature","2024-12-19",{"date":148,"type":33},"2024-12-20",{"date":150,"type":22},"2025-01",{"date":152,"type":22},"2027-07",{"name":39,"class":40},""]